Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YOL100W | PKH2 | SGDID:S000005460 | TTN |
Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14) |
2.7.11.1 | Homo sapiens | Muscular Disease,Heart Disease,Constrictive Pericarditis,Congenital Fiber-Type Disproportion,Mitral Valve Insufficiency,Aortic Valve Disease 2,Congenital Structural Myopathy,Myopathy,Amyloidosis,Cardiomyopathy, Dilated, 1e,Syncope,Myofibrillar Myopathy,Atrial Heart Septal Defect,Mitochondrial Dna Depletion Syndrome 12b,Childhood-Onset Progressive Contractures-Limb-Girdle Weakness-Muscle Dystrophy Syndrome,Emery-Dreifuss Muscular Dystrophy,Cortical Thymoma,Muscle Tissue Disease,Morvan'S Fibrillary Chorea,Neuromuscular Disease,Hypertrophic Cardiomyopathy,Familial Isolated Dilated Cardiomyopathy,Rasopathy,Autosomal Dominant Distal Myopathy,Lung Large Cell Carcinoma,Myopathy, Distal, 1,Myositis,Myotonic Dystrophy 1,Systolic Heart Failure,Myopathy, Myofibrillar, 1,Diastolic Heart Failure,Autosomal Recessive Limb-Girdle Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2a,Muscular Dystrophy,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2g,Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2j,Muscular Atrophy,Tibial Muscular Dystrophy,Limb-Girdle Muscular Dystrophy,Arrhythmogenic Right Ventricular Dysplasia, Familial, 1,Epithelial Malignant Thymoma,Hyaline Body Myopathy,Isolated Elevated Serum Creatine Phosphokinase Levels,Noonan Syndrome 1,Newborn Respiratory Distress Syndrome,Thymus Clear Cell Carcinoma,Reducing Body Myopathy,Myocarditis,Atrial Standstill 1,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 10,Hereditary Proximal Myopathy With Early Respiratory Failure,Dilated Cardiomyopathy,Alcoholic Cardiomyopathy,Lmna-Related Dilated Cardiomyopathy,Thymus Gland Disease,Long Qt Syndrome,Cardiomyopathy, Dilated, 1dd,Heart Conduction Disease,Udd Distal Myopathy - Tibial Muscular Dystrophy,Muscular Dystrophy, Congenital, Lmna-Related,Neuropathy,Perinephritis,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Right Dominant Form,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Biventricular Form,Familial Isolated Arrhythmogenic Ventricular Dysplasia, Left Dominant Form,Myopathy, Myofibrillar, 3,Sick Sinus Syndrome,Multiminicore Disease,Cardiomyopathy, Familial Hypertrophic, 4,Cardiomyopathy, Dilated, 1a,Congestive Heart Failure,Myopathy, Myofibrillar, 4,Left Ventricular Noncompaction 2,Foot Drop,Myopathy, Myofibrillar, 5,Rhabdomyosarcoma,Rigid Spine Muscular Dystrophy 1,Epidermolysis Bullosa Simplex With Muscular Dystrophy,Thymoma,Thymus Cancer,Dendritic Cell Thymoma,Respiratory Failure,Centronuclear Myopathy,Myopathy, Myofibrillar, 9, With Early Respiratory Failure,Cardiomyopathy, Dilated, 1g,Congenital Myasthenic Syndrome,Cardiomyopathy, Familial Hypertrophic, 9,Cardiomyopathy, Dilated, 1h,Orthostatic Intolerance,Emery-Dreifuss Muscular Dystrophy 2, Autosomal Dominant,Lung Squamous Cell Carcinoma,Restrictive Cardiomyopathy,Extrinsic Cardiomyopathy,Lambert-Eaton Myasthenic Syndrome,Arrhythmogenic Right Ventricular Cardiomyopathy,Brugada Syndrome,Muscle Hypertrophy,Salih Myopathy,Nonaka Myopathy,Primary Cutaneous Amyloidosis,Distal Arthrogryposis,Familial Atrial Fibrillation,Hypermethioninemia Due To Adenosine Kinase Deficiency,Atrioventricular Block,Third-Degree Atrioventricular Block,Barth Syndrome,Cardioneuromyopathy With Hyaline Masses And Nemaline Rods,Cardiomyopathy, Familial Hypertrophic, 1,Wolff-Parkinson-White Syndrome,Muscular Dystrophy-Dystroglycanopathy , Type C, 5,Intrinsic Cardiomyopathy,Peripartum Cardiomyopathy,Lipoprotein Quantitative Trait Locus,Atrial Fibrillation,Scoliosis,Muscular Dystrophy, Duchenne Type,Myopathy, Centronuclear, X-Linked,Cardiac Arrest,Inguinal Hernia,Muscular Dystrophy, Limb-Girdle, Autosomal Recessive 2,Myasthenia Gravis,Left Ventricular Noncompaction,Lethal Congenital Contracture Syndrome,Myopathy, Centronuclear, 2,Batten-Turner Congenital Myopathy,Miyoshi Muscular Dystrophy,Tibial Muscular Dystrophy, Tardive,Cardiomyopathy, Dilated, 1b |
1tki_b | Q8WZ42 | ENSG00000155657 | TTN | 98.70 | 3.80E-12 | 4.50E-16 | 127.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | SNRK KIAA0096 SNFRK |
SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase) |
2.7.11.1 | Homo sapiens | Breast Angiosarcoma,Skin Angiosarcoma,Liver Angiosarcoma,Skin Sarcoma,Lymphangiosarcoma,Breast Sarcoma,Hydrolethalus Syndrome 1,Neuronopathy, Distal Hereditary Motor, Type Viii |
5yks_b | Q9NRH2 | ENSG00000163788 | SNRK | 98.40 | 3.50E-11 | 4.10E-15 | 124.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | cotI ytaA BSU30920 |
Spore coat protein I |
Bacillus subtilis | 2q83_a | O34656 | 98.60 | 8.80E-12 | 1.10E-15 | 122.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | PRKCB PKCB PRKCB1 |
Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) |
2.7.11.13 | Homo sapiens | Severe Nonproliferative Diabetic Retinopathy,Hyperglycemia,Macroglobulinemia,Diabetic Macular Edema,Microvascular Complications Of Diabetes 5,Diabetes Mellitus,Macular Retinal Edema,B-Cell Lymphoma,Myotonic Dystrophy 1,Primary Biliary Cholangitis,Diabetic Neuropathy,Kidney Disease,Eye Disease,Glioblastoma,Hepatocellular Carcinoma,Type 2 Diabetes Mellitus,Leukemia, Chronic Lymphocytic,Autism,Lung Cancer |
2i0e_a | P05771 | ENSG00000166501 | PRKCB | 98.80 | 1.10E-12 | 1.30E-16 | 132.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | Btk Bpk |
Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) |
2.7.10.2 | Mus musculus | 4xi2_a | P35991 | 98.50 | 2.20E-11 | 2.70E-15 | 126.80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | CRK2 PK5 |
Cell division control protein 2 homolog (EC 2.7.11.22) (EC 2.7.11.23) (PfPK5) |
2.7.11.22,2.7.11.23, | Plasmodium falciparum | 1v0o_a | Q07785 | 98.50 | 2.50E-11 | 3.20E-15 | 117.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | SRK2I 41K OSKL2 SNRK2.3 At5g66880 MUD21.14 |
Serine/threonine-protein kinase SRK2I (EC 2.7.11.1) (OST1-kinase-like 2) (Protein ATHPROKIN B) (SNF1-related kinase 2.3) (SnRK2.3) |
2.7.11.1 | Arabidopsis thaliana | 3uc3_a | Q39193 | 98.50 | 1.90E-11 | 2.30E-15 | 124.20 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | ULK3 |
Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) |
2.7.11.1 | Homo sapiens | 6fdy_u | Q6PHR2 | ENSG00000140474 | ULK3 | 98.40 | 3.20E-11 | 4.10E-15 | 115.50 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YOL100W | PKH2 | SGDID:S000005460 | NEK1 KIAA1901 |
Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55) |
2.7.11.1 | Homo sapiens | Polycystic Kidney Disease,Uterine Adnexa Cancer,Cor Triatriatum,Cor Triatriatum Dexter,Amyotrophic Lateral Sclerosis 1,Short-Rib Thoracic Dysplasia 12,Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 1,Lateral Sclerosis,Motor Neuron Disease,Nephronophthisis,Short-Rib Thoracic Dysplasia 3 With Or Without Polydactyly,Fundus Dystrophy,Kidney Disease,Ellis-Van Creveld Syndrome,Amyotrophic Lateral Sclerosis 24,Polydactyly,Mega-Corpus-Callosum Syndrome With Cerebellar Hypoplasia And Cortical Malformations,Cranioectodermal Dysplasia,Asphyxiating Thoracic Dystrophy,Weyers Acrofacial Dysostosis,Mohr Syndrome,Short-Rib Thoracic Dysplasia 1 With Or Without Polydactyly,Frontotemporal Dementia,Joubert Syndrome 1,Short-Rib Thoracic Dysplasia 6 With Or Without Polydactyly |
4apc_b | Q96PY6 | ENSG00000137601 | NEK1 | 98.50 | 2.30E-11 | 2.80E-15 | 123.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | SGK1 SGK |
Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) |
2.7.11.1 | Homo sapiens | Plasma Cell Neoplasm,Pseudohypoaldosteronism,Cystic Fibrosis,Gastric Cancer,Disease Of Mental Health,Liddle Syndrome 1,Body Mass Index Quantitative Trait Locus 11,Pseudohypoaldosteronism, Type I, Autosomal Dominant,Tuberous Sclerosis 1,Hypertension, Essential,Rett Syndrome,Myeloma, Multiple |
2r5t_a | O00141 | ENSG00000118515 | SGK1 | 98.60 | 5.70E-12 | 6.90E-16 | 129.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | RPS6KA5 MSK1 |
Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) |
2.7.11.1 | Homo sapiens | Septic Myocarditis,Coffin-Lowry Syndrome |
3kn5_b | O75582 | ENSG00000100784 | RPS6KA5 | 98.50 | 2.00E-11 | 2.40E-15 | 121.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CSNK2A2 CK2A2 |
Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Connective Tissue Disease,Neonatal Leukemia,Distal Muscular Dystrophy With Anterior Tibial Onset,Spermatogenic Failure 50,Breast Adenocarcinoma,Theileriasis,Spermatogenic Failure 9 |
6hmq_a | P19784 | ENSG00000070770 | CSNK2A2 | 98.50 | 1.70E-11 | 2.00E-15 | 125.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | DAPK1 DAPK |
Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Squamous Cell Carcinoma,Childhood Acute Lymphocytic Leukemia,Lung Cancer Susceptibility 3,Adenoid Cystic Carcinoma,Cholecystitis,Alzheimer Disease,B-Cell Lymphoma,Mixed Oligodendroglioma-Astrocytoma,Transitional Cell Carcinoma,Bladder Cancer,Tuberous Sclerosis 2,Parkinson Disease, Late-Onset,Colorectal Cancer,Pediatric Lymphoma,Oligodendroglioma,Central Neurocytoma,Ischemia,Gastric Cancer,Pancreatic Ductal Adenocarcinoma,Cholangiocarcinoma,Cervical Cancer,Cervical Squamous Cell Carcinoma,Myelodysplastic Syndrome,Nasopharyngeal Carcinoma,Lung Cancer |
2w4k_a | P53355 | ENSG00000196730 | DAPK1 | 98.50 | 2.00E-11 | 2.50E-15 | 119.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | MELK KIAA0175 |
Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) |
2.7.10.2 | Homo sapiens | Colorectal Cancer |
5k00_a | Q14680 | ENSG00000165304 | MELK | 98.70 | 2.90E-12 | 3.50E-16 | 129.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | ULK2 KIAA0623 |
Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) |
2.7.11.1 | Homo sapiens | 6qau_a | Q8IYT8 | ENSG00000083290 | ULK2 | 98.50 | 1.40E-11 | 1.70E-15 | 118.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YOL100W | PKH2 | SGDID:S000005460 | MKNK2 GPRK7 MNK2 |
MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) |
2.7.11.1 | Homo sapiens | 2ac3_a | Q9HBH9 | ENSG00000099875 | MKNK2 | 98.50 | 3.00E-11 | 3.70E-15 | 118.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YOL100W | PKH2 | SGDID:S000005460 | ROP8 |
ROP8 |
Toxoplasma gondii | 3byv_a | O15693 | 98.50 | 1.90E-11 | 2.30E-15 | 125.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Bos taurus | 2uzv_a | P00517 | 98.60 | 5.30E-12 | 6.40E-16 | 127.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | AKT1 PKB RAC |
RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) |
2.7.11.1 | Homo sapiens | Adult Hepatocellular Carcinoma,Breast Papillomatosis,Esophageal Disease,Pancreatic Adenocarcinoma,Muscular Disease,Skin Melanoma,Liver Disease,Mitral Valve Disease,Heart Disease,Neurofibromatosis, Type Ii,Endometrial Cancer,Bile Duct Disease,Spinal Chordoma,Hepatopulmonary Syndrome,Squamous Cell Carcinoma,Pfeiffer Syndrome,Glucose Metabolism Disease,Childhood T-Cell Acute Lymphoblastic Leukemia,Hyperglycemia,Retinitis Pigmentosa,Thyroid Gland Cancer,Hair Disease,Macroglobulinemia,Lung Cancer Susceptibility 3,Kagami-Ogata Syndrome,Adenoid Cystic Carcinoma,Non-Alcoholic Fatty Liver Disease,Chordoma,Cowden Syndrome,Polycystic Kidney Disease,Microvascular Complications Of Diabetes 5,Suppression Of Tumorigenicity 12,Melanoma,Connective Tissue Disease,Ocular Hypertension,Leukemia, Chronic Myeloid,Overnutrition,Inherited Metabolic Disorder,Thyroid Gland Anaplastic Carcinoma,Diabetes Mellitus,Adenoma,Spherocytosis, Type 5,Cowden Syndrome 1,Breast Juvenile Papillomatosis,Lipid Storage Disease,Peripheral Nervous System Neoplasm,Uterine Corpus Cancer,Connective Tissue Cancer,Bone Sarcoma,Hypertrophic Cardiomyopathy,Placental Choriocarcinoma,Leukocyte Disease,Clear Cell Renal Cell Carcinoma,Hyperostosis,Alzheimer Disease,Hepatoblastoma,Rasopathy,Nasopharyngeal Disease,Myocardial Infarction,Major Depressive Disorder,Bile Duct Cancer,Intestinal Benign Neoplasm,Stroke, Ischemic,Teeth Hard Tissue Disease,Amyotrophic Lateral Sclerosis 1,Malignant Ovarian Surface Epithelial-Stromal Neoplasm,Ovary Epithelial Cancer,T-Cell Lymphoblastic Leukemia/Lymphoma,Ocular Cancer,Amelogenesis Imperfecta,Retinal Cancer,Blood Platelet Disease,Biliary Tract Disease,Congenital Lipomatous Overgrowth, Vascular Malformations, And Epidermal Nevi,Infratentorial Cancer,Leptin Deficiency Or Dysfunction,Lymphatic System Disease,Neurofibromatosis, Type I,Insulin-Like Growth Factor I,Neuroblastoma,Colonic Benign Neoplasm,Subependymal Glioma,Blood Coagulation Disease,Benign Ependymoma,Pilocytic Astrocytoma,Diffuse Astrocytoma,Childhood Leukemia,Bile Duct Adenocarcinoma,Hemangioma Of Lung,Nevus, Epidermal,Distal Muscular Dystrophy With Anterior Tibial Onset,Retinal Vascular Disease,Psychotic Disorder,Leukemia, Acute Myeloid,Noonan Syndrome 1,Bone Marrow Cancer,Leber Plus Disease,Hemangioma,Leukemia, Acute Lymphoblastic,Cataract,Combined Immunodeficiency,Liver Cirrhosis,Pancreas Disease,Papilloma,Cardiovascular System Disease,Autonomic Nervous System Neoplasm,Kidney Cancer,Pleural Cancer,Basal Cell Nevus Syndrome,Cowden Syndrome 6,Bladder Cancer,Focal Segmental Glomerulosclerosis,Epithelial-Myoepithelial Carcinoma,Thymus Gland Disease,Brain Cancer,Colonic Disease,Lung Adenoma,Lung Oat Cell Carcinoma,Endometrial Adenocarcinoma,Oropharynx Cancer,Cervix Carcinoma,Ulcerative Colitis,Nervous System Disease,Osteoporosis,Anal Squamous Cell Carcinoma,Ovarian Cancer,Adenocarcinoma,Tuberous Sclerosis 2,In Situ Carcinoma,Tuberous Sclerosis,T-Cell Acute Lymphoblastic Leukemia,Eye Disease,Acute Megakaryocytic Leukemia,Breast Carcinoma In Situ,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Malignant Astrocytoma,Gliosarcoma,Parkinson Disease, Late-Onset,Colorectal Cancer,Peripheral Nervous System Disease,Nervous System Cancer,Ovarian Serous Cystadenocarcinoma,Cystadenocarcinoma,Serous Cystadenocarcinoma,Gallbladder Cancer,Hepatocellular Carcinoma,Premature Menopause,Combined Hepatocellular Carcinoma And Cholangiocarcinoma,Skin Papilloma,Partial Third-Nerve Palsy,Neurilemmoma,Rhabdomyosarcoma,Ischemia,Tongue Disease,Chronic Granulomatous Disease,Thymoma,Thymus Cancer,Ovarian Disease,Noonan Syndrome With Multiple Lentigines,Polycystic Kidney Disease 1 With Or Without Polycystic Liver Disease,Teratoma,Bipolar Disorder,Macular Degeneration, Age-Related, 1,Immunodeficiency 14,Sarcoma,Bone Osteosarcoma,Skin Carcinoma,Gastric Cancer,Breast Adenocarcinoma,Cone-Rod Dystrophy 2,Prostate Cancer,Disease Of Mental Health,Pancreatic Ductal Adenocarcinoma,Cholangiocarcinoma,Proteus Syndrome,Cervical Cancer,Toxic Encephalopathy,Ovarian Cystadenocarcinoma,Body Mass Index Quantitative Trait Locus 11,Penile Disease,Contractures, Pterygia, And Spondylocarpotarsal Fusion Syndrome 1a,Central Nervous System Cancer,Pulmonary Fibrosis, Idiopathic,Congenital Myasthenic Syndrome,Retinitis Pigmentosa 47,Respiratory System Disease,Integumentary System Disease,Skin Disease,Cervical Adenocarcinoma,Ovary Adenocarcinoma,Gastric Adenocarcinoma,Type 2 Diabetes Mellitus,Plasmacytoma,Cervical Squamous Cell Carcinoma,Lynch Syndrome,Hidradenoma,Lung Squamous Cell Carcinoma,Fragile X Syndrome,Thyroid Gland Follicular Carcinoma,Schizophrenia,Sensory System Disease,Bladder Urothelial Carcinoma,Lymphoma, Non-Hodgkin, Familial,Skeletal Muscle Cancer,Muscle Cancer,Small Cell Cancer Of The Lung,Immunodeficiency 36,Hypotrichosis 1,Exanthem,Esophageal Cancer,Severe Congenital Neutropenia,Respiratory System Benign Neoplasm,Reproductive Organ Benign Neoplasm,Gastrointestinal System Benign Neoplasm,Immune Deficiency Disease,Myelodysplastic Syndrome,Meningioma, Radiation-Induced,Wiskott-Aldrich Syndrome,X-Linked Monogenic Disease,Autosomal Genetic Disease,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Peripheral T-Cell Lymphoma,Tuberous Sclerosis 1,Hashimoto Thyroiditis,Gastrointestinal Stromal Tumor,Diabetic Encephalopathy,Tongue Squamous Cell Carcinoma,Oral Squamous Cell Carcinoma,Huntington Disease,Renal Cell Carcinoma, Nonpapillary,Nasopharyngeal Carcinoma,Hypertension, Essential,Meningioma, Familial,Pre-Malignant Neoplasm,Lymphatic System Cancer,Ductal Carcinoma In Situ,Estrogen-Receptor Positive Breast Cancer,Cell Type Benign Neoplasm,Cardiovascular Organ Benign Neoplasm,Uterine Benign Neoplasm,Acquired Metabolic Disease,Kaposi Sarcoma,Colitis,Klippel-Trenaunay-Weber Syndrome,Gallbladder Disease,Leukemia, Chronic Lymphocytic,Amelogenesis Imperfecta, Type Ig,Systemic Lupus Erythematosus,Pelizaeus-Merzbacher Disease,Rett Syndrome,Myeloma, Multiple,Medulloblastoma,Spinal Disease,Autism,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Lymphoproliferative Syndrome,Lung Cancer,Palmoplantar Keratoderma, Bothnian Type,Oculoectodermal Syndrome,Osteogenic Sarcoma,Pancreatic Cancer |
4gv1_a | P31749 | ENSG00000142208 | AKT1 | 98.80 | 6.00E-13 | 7.30E-17 | 134.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | BTK AGMX1 ATK BPK |
Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) |
2.7.10.2 | Homo sapiens | Pneumocystosis,X-Linked Recessive Disease,Lymphopenia,Conjunctivitis,Richter'S Syndrome,Macroglobulinemia,Pyoderma,Cll/Sll,Mast-Cell Leukemia,Polyarticular Juvenile Idiopathic Arthritis,Spherocytosis, Type 5,Ecthyma,B Cell Deficiency,Lung Large Cell Carcinoma,B-Cell Lymphoma,Common Variable Immunodeficiency,Neutropenia,Agammaglobulinemia 1, Autosomal Recessive,Plasma Protein Metabolism Disease,Isolated Agammaglobulinemia,Poliomyelitis,Leukemia, Acute Myeloid,Growth Hormone Deficiency,Leukemia, Acute Lymphoblastic,Agammaglobulinemia,Bacterial Infectious Disease,Breast Cancer,Central Nervous System Hematologic Cancer,Congenital Hypogammaglobulinemia,Immunodeficiency 14,Panniculitis,Immunodeficiency 33,Lymphoma, Non-Hodgkin, Familial,Baylisascariasis,Agammaglobulinemia, X-Linked,Paralytic Poliomyelitis,Immune Deficiency Disease,Myelodysplastic Syndrome,Immunoglobulin A Deficiency 1,Wiskott-Aldrich Syndrome,X-Linked Monogenic Disease,Diffuse Large B-Cell Lymphoma,Mantle Cell Lymphoma,Lymphoplasmacytic Lymphoma,Marginal Zone B-Cell Lymphoma,Splenic Marginal Zone Lymphoma,Williams-Beuren Syndrome,Combined Oxidative Phosphorylation Deficiency 9,Mohr-Tranebjaerg Syndrome,Cd40 Ligand Deficiency,Isolated Growth Hormone Deficiency, Type Iii, With Agammaglobulinemia,Immunodeficiency 45,Immunodeficiency With Hyper-Igm, Type 1,Leukemia, Chronic Lymphocytic,Myeloma, Multiple,Isolated Growth Hormone Deficiency,Isolated Growth Hormone Deficiency Type Iii,Waldenstroem'S Macroglobulinemia |
6aua_a | Q06187 | ENSG00000010671 | BTK | 98.50 | 2.80E-11 | 3.50E-15 | 114.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | ROCK2 |
Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) |
2.7.11.1 | Bos taurus | 2f2u_b | Q28021 | 98.70 | 1.40E-12 | 1.70E-16 | 136.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | Brsk2 Kiaa4256 Sada |
Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase SAD-A) |
2.7.11.26 | Mus musculus | 4ynz_b | Q69Z98 | 98.60 | 4.70E-12 | 5.70E-16 | 128.10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | MASTL GW GWL THC2 |
Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L) |
2.7.11.1 | Homo sapiens | Autosomal Thrombocytopenia With Normal Platelets,Sick Building Syndrome,Thrombocytopenia,Thrombocytopenia 2,Gray Platelet Syndrome,Ceroid Lipofuscinosis, Neuronal, 2 |
5loh_a | Q96GX5 | ENSG00000120539 | MASTL | 98.70 | 1.90E-12 | 2.30E-16 | 131.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | nahK lnpB BLLJ_1622 |
N-acetylhexosamine 1-kinase (EC 2.7.1.162) (N-acetylgalactosamine/N-acetylglucosamine 1-kinase) |
2.7.1.162 | Bifidobacterium longum | 4wh3_a | E8MF12 | 99.10 | 3.60E-15 | 4.70E-19 | 147.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | CDC42BPB KIAA1124 |
Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) |
2.7.11.1 | Homo sapiens | Myotonic Dystrophy,Epidermolysis Bullosa Simplex, Dowling-Meara Type |
5ote_a | Q9Y5S2 | ENSG00000198752 | CDC42BPB | 98.60 | 4.70E-12 | 5.50E-16 | 132.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | ssp2 SPCC74.03c |
SNF1-like protein kinase ssp2 (EC 2.7.11.1) |
2.7.11.1 | Schizosaccharomyces pombe | 3h4j_b | O74536 | 98.60 | 4.90E-12 | 5.90E-16 | 127.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | PRKACA PKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Homo sapiens | Mixed Fibrolamellar Hepatocellular Carcinoma,Fibrolamellar Carcinoma,Cardioacrofacial Dysplasia 1,Dilated Cardiomyopathy,Acth-Independent Cushing Syndrome,Osteoporosis,Breast Cancer,Pigmented Nodular Adrenocortical Disease, Primary, 4,Primary Pigmented Nodular Adrenocortical Disease |
3ama_a | P17612 | ENSG00000072062 | PRKACA | 98.60 | 4.10E-12 | 4.90E-16 | 129.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | RPS6KA3 ISPK1 MAPKAPK1B RSK2 |
Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) |
2.7.11.1 | Homo sapiens | Ventricular Septal Defect,Learning Disability,Symptomatic Form Of Coffin-Lowry Syndrome In Female Carriers,Cohen Syndrome,Specific Learning Disability,Gastroesophageal Reflux,Breast Cancer,Cardiomyopathy, Familial Hypertrophic, 4,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Chromosome 16p13.3 Deletion Syndrome, Proximal,Orthostatic Intolerance,Dyskeratosis Congenita, Autosomal Dominant 3,X-Linked Monogenic Disease,Non-Syndromic X-Linked Intellectual Disability,Coffin-Lowry Syndrome,Hypertelorism,Partington X-Linked Mental Retardation Syndrome,Scoliosis |
4d9u_a | P51812 | ENSG00000177189 | RPS6KA3 | 98.60 | 4.60E-12 | 5.50E-16 | 128.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PRKG1 PRKG1B PRKGR1A PRKGR1B |
cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) |
2.7.11.12 | Homo sapiens | Myopathy,Impotence,Connective Tissue Disease,Diabetes Mellitus,Aortic Dissection,Alzheimer Disease,Familial Thoracic Aortic Aneurysm And Aortic Dissection,Cystic Fibrosis,Aortic Disease,Aortic Valve Disease 1,Heritable Thoracic Aortic Disease,Hemolytic Anemia,Non-Proliferative Fibrocystic Change Of The Breast,Aneurysm,Aortic Aneurysm, Familial Thoracic 8,Disease Of Mental Health,Pulmonary Hypertension,Body Mass Index Quantitative Trait Locus 11,Aortic Aneurysm,Loeys-Dietz Syndrome,Immune Deficiency Disease,Myelodysplastic Syndrome,Attention Deficit-Hyperactivity Disorder,Aortic Aneurysm, Familial Thoracic 1,Hypertension, Essential,Sexual Disorder |
6bg2_a | Q13976 | ENSG00000185532 | PRKG1 | 98.70 | 3.60E-12 | 4.30E-16 | 129.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | MAP4K3 RAB8IPL1 |
Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) |
2.7.11.1 | Homo sapiens | Adult-Onset Still'S Disease |
5j5t_a | Q8IVH8 | ENSG00000011566 | MAP4K3 | 98.80 | 5.10E-13 | 6.10E-17 | 137.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | WNK3 KIAA1566 PRKWNK3 |
Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) |
2.7.11.1 | Homo sapiens | Bartter Disease,Renal Tubular Transport Disease,Pseudohypoaldosteronism,Agenesis Of The Corpus Callosum With Peripheral Neuropathy,Arthrogryposis, Distal, Type 3,Liddle Syndrome 1,Hypomagnesemia 4, Renal,Distal Arthrogryposis,Hypertension, Essential,Syndromic X-Linked Intellectual Disability Siderius Type,Gitelman Syndrome |
5o2c_a | Q9BYP7 | ENSG00000196632 | WNK3 | 98.50 | 3.30E-11 | 3.90E-15 | 124.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | DCLK1 DCAMKL1 DCDC3A KIAA0369 |
Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1) |
2.7.11.1 | Homo sapiens | Zellweger Syndrome,Colorectal Cancer,Attention Deficit-Hyperactivity Disorder,Chemical Colitis,Band Heterotopia |
5jzj_b | O15075 | ENSG00000133083 | DCLK1 | 98.50 | 2.00E-11 | 2.40E-15 | 119.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | MAP4K4 HGK KIAA0687 NIK |
Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase) |
2.7.11.1 | Homo sapiens | Arteriovenous Malformations Of The Brain,Autosomal Recessive Distal Hereditary Motor Neuronopathy,Spinal Muscular Atrophy, Distal, Autosomal Recessive, 1,Theileriasis |
4u3y_a | O95819 | ENSG00000071054 | MAP4K4 | 98.50 | 1.20E-11 | 1.50E-15 | 123.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) |
2.7.11.11 | Cricetulus griseus | 5n3j_a | P25321 | 98.70 | 2.10E-12 | 2.50E-16 | 131.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | MAP2K1 MEK1 PRKMK1 |
Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) |
2.7.12.2 | Homo sapiens | Melorheostosis, Isolated,Skin Melanoma,Achondroplasia,Heart Disease,Ichthyosis,Squamous Cell Carcinoma,Cerebral Hemisphere Lipoma,Corpus Callosum Lipoma,Lung Cancer Susceptibility 3,Melorheostosis,Pulmonary Valve Stenosis,Suppression Of Tumorigenicity 12,Melanoma,Acneiform Dermatitis,Neurofibromatosis-Noonan Syndrome,Hypertrophic Cardiomyopathy,Osteopoikilosis,Alzheimer Disease,Rasopathy,Noonan Syndrome-Like Disorder With Loose Anagen Hair,Keratosis Pilaris Atrophicans Faciei,Costello Syndrome,Anthrax Disease,Extracranial Arteriovenous Malformation,Neurofibromatosis, Type I,Neuroblastoma,Skin Granular Cell Tumor,Pseudo-Turner Syndrome,Leukemia, Acute Myeloid,Noonan Syndrome 1,Senile Angioma,Hemangioma,Rosai-Dorfman Disease,Bladder Cancer,Mixed Cell Adenoma,Hairy Cell Leukemia,Prostate Squamous Cell Carcinoma,Noonan Syndrome-Like Disorder With Loose Anagen Hair 2,Cardiofaciocutaneous Syndrome 3,Ovarian Cancer,Myeloid Leukemia,Adenocarcinoma,Breast Cancer,Squamous Cell Carcinoma, Head And Neck,Colorectal Cancer,Pulmonary Valve Disease,Hepatocellular Carcinoma,Cardiofaciocutaneous Syndrome 1,Splenic Diffuse Red Pulp Small B-Cell Lymphoma,Pheochromocytoma,Rhabdomyosarcoma,Noonan Syndrome With Multiple Lentigines,Fibrosarcoma,Histiocytosis,Skin Carcinoma,Gastric Cancer,Arteriovenous Malformation,Prostate Cancer,Disease Of Mental Health,Gastric Adenocarcinoma,Langerhans Cell Histiocytosis,Bladder Urothelial Carcinoma,Lymphoma, Non-Hodgkin, Familial,Diamond-Blackfan Anemia 20,Acute Promyelocytic Leukemia,Ovarian Melanoma,Autism Spectrum Disorder,Kaposi Sarcoma,Cardiomyopathy, Familial Hypertrophic, 25,Medulloblastoma,Autism,Melanoma, Cutaneous Malignant 1,Melanoma, Uveal,Lung Cancer,Pancreatic Cancer |
3sls_b | Q02750 | ENSG00000169032 | MAP2K1 | 98.50 | 2.30E-11 | 2.80E-15 | 119.90 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | unc-22 ZK617.1 |
Twitchin (EC 2.7.11.1) (Uncoordinated protein 22) |
2.7.11.1 | Caenorhabditis elegans | 3uto_a | Q23551 | 98.50 | 1.40E-11 | 1.70E-15 | 132.80 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | PKH2 PKH1 CAALFM_C112410CA CaO19.12690 CaO19.5224 orf19.5224 |
Serine/threonine-protein kinase PKH2 (EC 2.7.11.1) (PKB-activating kinase homolog 2) |
2.7.11.1 | Candida albicans | 4c0t_a | Q5A3P6 | 99.30 | 8.20E-17 | 7.10E-21 | 193.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | MAP4K1 HPK1 |
Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1) |
2.7.11.1 | Homo sapiens | 6cqd_b | Q92918 | ENSG00000104814 | MAP4K1 | 98.60 | 4.80E-12 | 6.10E-16 | 123.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YOL100W | PKH2 | SGDID:S000005460 | ABAYE3578 |
ABAYE3578 |
2.7.1.95 | Acinetobacter baumannii | 4gkh_c | B0VD92 | 98.60 | 5.60E-12 | 7.60E-16 | 116.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | MARK1 KIAA1477 MARK |
Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) |
2.7.11.26 | Homo sapiens | Alzheimer Disease,Peutz-Jeghers Syndrome,Autism |
6c9d_a | Q9P0L2 | ENSG00000116141 | MARK1 | 98.60 | 9.30E-12 | 1.00E-15 | 133.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PBL2 APK2A KIN1 At1g14370 F14L17.14 |
Probable serine/threonine-protein kinase PBL2 (EC 2.7.11.1) (PBS1-like protein 2) (Protein kinase 2A) |
2.7.11.1 | Arabidopsis thaliana | 6j5t_d | O49839 | 98.70 | 3.20E-12 | 3.80E-16 | 133.80 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | aphA |
Aminoglycoside 3'-phosphotransferase (EC 2.7.1.95) (APH(3')III) (Kanamycin kinase, type III) (Neomycin-kanamycin phosphotransferase type III) |
2.7.1.95 | Enterococcus faecalis | 3tm0_a | P0A3Y5 | 98.70 | 1.50E-12 | 2.00E-16 | 118.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | GSK3B |
Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) |
2.7.11.26 | Homo sapiens | Liver Disease,Endometrial Cancer,Epilepsy,Polycystic Kidney Disease,Diabetes Mellitus,Alzheimer Disease,Major Depressive Disorder,Neuroblastoma,Cervical Non-Keratinizing Squamous Cell Carcinoma,Barbiturate Dependence,Alzheimer Disease 9,Dementia,Fallopian Tube Serous Adenocarcinoma,Breast Cancer,Parkinson Disease, Late-Onset,Colorectal Cancer,Parkinson Disease 1, Autosomal Dominant,Hepatocellular Carcinoma,Bipolar Disorder,Gastric Cancer,Prostate Cancer,Disease Of Mental Health,Type 2 Diabetes Mellitus,Schizophrenia,Ophthalmomyiasis,Familial Adenomatous Polyposis,Severe Congenital Neutropenia,Aneurysmal Bone Cysts,Attention Deficit-Hyperactivity Disorder,Medulloblastoma,Frontotemporal Dementia,Pancreatic Cancer |
1j1b_b | P49841 | ENSG00000082701 | GSK3B | 98.50 | 2.50E-11 | 3.00E-15 | 126.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | ROCK1 |
Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) |
2.7.11.1 | Homo sapiens | Coronary Artery Vasospasm,Ocular Hyperemia,Breast Cancer,Pediatric Osteosarcoma,Hutchinson-Gilford Progeria Syndrome,Tetralogy Of Fallot,Hypertension, Essential,Lung Cancer |
2v55_c | Q13464 | ENSG00000067900 | ROCK1 | 98.70 | 1.90E-12 | 2.20E-16 | 135.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | pck spr1147 |
pck spr1147 |
Streptococcus pneumoniae | 4r78_a | Q8DPI4 | 98.50 | 1.80E-11 | 2.20E-15 | 120.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | PKMYT1 MYT1 |
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase) |
2.7.11.1 | Homo sapiens | 5vcy_a | Q99640 | ENSG00000127564 | PKMYT1 | 98.60 | 5.10E-12 | 6.30E-16 | 124.40 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YOL100W | PKH2 | SGDID:S000005460 | CASK LIN2 |
Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog) |
2.7.11.1 | Homo sapiens | Cask-Related Disorders,Cerebellar Hypoplasia,Constipation,Congenital Nystagmus,Pathologic Nystagmus,Neurofibromatosis, Type I,Fraser Syndrome 1,Cask Disorders,Cerebellar Disease,Dystonia,Glucosephosphate Dehydrogenase Deficiency,Lobular Neoplasia,X-Linked Intellectual Disability, Najm Type,Cask-Related Intellectual Disability,Microcephaly,Hypertonia,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Fg Syndrome 4,Helsmoortel-Van Der Aa Syndrome,Aland Island Eye Disease,Developmental And Epileptic Encephalopathy 8,Mental Retardation And Microcephaly With Pontine And Cerebellar Hypoplasia,Anemia, Nonspherocytic Hemolytic, Due To G6pd Deficiency,Coffin-Siris Syndrome 1,Early Infantile Epileptic Encephalopathy,Opitz-Kaveggia Syndrome,Pontocerebellar Hypoplasia,Autism,Cerebellar Hypoplasia/Atrophy, Epilepsy, And Global Developmental Delay,Peho Syndrome |
3c0g_b | O14936 | ENSG00000147044 | CASK | 98.50 | 2.50E-11 | 3.00E-15 | 124.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | STK10 LOK |
Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) |
2.7.11.1 | Homo sapiens | Testicular Germ Cell Tumor |
4bc6_a | O94804 | ENSG00000072786 | STK10 | 98.50 | 2.40E-11 | 3.10E-15 | 117.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | RPS6KB1 STK14A |
Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) |
2.7.11.1 | Homo sapiens | Mitral Valve Disease,Retinitis Pigmentosa,Cowden Syndrome,Pyriform Sinus Cancer,Cowden Syndrome 1,Placental Choriocarcinoma,Uterus Perivascular Epithelioid Cell Tumor,Subependymal Glioma,Benign Ependymoma,Leukemia, Acute Myeloid,Nephronophthisis,Kidney Angiomyolipoma,Aortic Disease,Skin Amelanotic Melanoma,Ovarian Cancer,Tuberous Sclerosis 2,Tuberous Sclerosis,Breast Cancer,Glioblastoma,Colorectal Cancer,Hepatocellular Carcinoma,Rhabdomyosarcoma,Acute Laryngopharyngitis,Gastric Cancer,Prostate Cancer,Disease Of Mental Health,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Diamond-Blackfan Anemia 20,Esophageal Cancer,Muscle Hypertrophy,Mantle Cell Lymphoma,Tuberous Sclerosis 1,Lymphangioleiomyomatosis,Leukodystrophy, Hypomyelinating, 12,Lung Cancer,Palmoplantar Keratoderma, Bothnian Type,Pancreatic Cancer |
3wf7_a | P23443 | ENSG00000108443 | RPS6KB1 | 98.60 | 4.00E-12 | 4.80E-16 | 127.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | pknB Rv0014c MTCY10H4.14c |
Serine/threonine-protein kinase PknB (EC 2.7.11.1) |
2.7.11.1 | Mycobacterium tuberculosis | 6i2p_a | P9WI81 | 98.60 | 4.00E-12 | 5.10E-16 | 120.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | PKN1 PAK1 PKN PRK1 PRKCL1 |
Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N) |
2.7.11.13 | Homo sapiens | 4otd_a | Q16512 | ENSG00000123143 | PKN1 | 98.70 | 1.90E-12 | 2.40E-16 | 129.90 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YOL100W | PKH2 | SGDID:S000005460 | DYRK2 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) |
2.7.12.1 | Homo sapiens | 4azf_a | Q92630 | ENSG00000127334 | DYRK2 | 98.50 | 1.60E-11 | 1.90E-15 | 128.90 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YOL100W | PKH2 | SGDID:S000005460 | Camk1 |
Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) |
2.7.11.17 | Rattus norvegicus | 1a06_a | Q63450 | 99.50 | 7.20E-19 | 7.50E-23 | 184.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | PLK2 SNK |
Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) |
2.7.11.21 | Homo sapiens | Epilepsy, Familial Temporal Lobe, 2 |
4i5p_a | Q9NYY3 | ENSG00000145632 | PLK2 | 98.70 | 3.00E-12 | 3.70E-16 | 127.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | DAPK3 ZIPK |
Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) |
2.7.11.1 | Homo sapiens | Recessive Dystrophic Epidermolysis Bullosa |
1yrp_a | O43293 | ENSG00000167657 | DAPK3 | 98.50 | 1.30E-11 | 1.60E-15 | 118.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | SNF1 CAT1 CCR1 GLC2 PAS14 YDR477W D8035.20 |
Carbon catabolite-derepressing protein kinase (EC 2.7.11.1) (Sucrose nonfermentating protein 1) |
2.7.11.1 | Saccharomyces cerevisiae | 2fh9_a | P06782 | 98.60 | 6.10E-12 | 7.70E-16 | 120.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | MAP3K8 COT ESTF |
Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25) (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2) (TPL-2) |
2.7.11.25 | Homo sapiens | Indolent Plasma Cell Myeloma,Paronychia,Skin Lipoma,Rheumatoid Arthritis,Lung Cancer |
4y85_b | P41279 | ENSG00000107968 | MAP3K8 | 98.50 | 2.00E-11 | 2.40E-15 | 122.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | DMPK DM1PK MDPK |
Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) |
2.7.11.1 | Homo sapiens | Muscular Disease,Fuchs' Endothelial Dystrophy,Myopathy,Muscle Tissue Disease,Neuromuscular Disease,Hypertrophic Cardiomyopathy,Myotonic Disease,Myotonic Dystrophy 1,Muscular Dystrophy,Myotonic Dystrophy,Spinocerebellar Ataxia 8,Myotonic Cataract,Cataract,Oculopharyngeal Muscular Dystrophy,Hair Follicle Neoplasm,Myotonic Dystrophy 2,Myotonia,Immature Cataract,Lens Disease,Autosomal Dominant Cerebellar Ataxia,Disease Of Mental Health,Fragile X Syndrome,Huntington Disease-Like 2,First-Degree Atrioventricular Block,Fragile X-Associated Tremor/Ataxia Syndrome,X-Linked Hereditary Ataxia,Spinal And Bulbar Muscular Atrophy, X-Linked 1,Catecholaminergic Polymorphic Ventricular Tachycardia,Frontotemporal Dementia,3-Methylglutaconic Aciduria, Type Iii |
2vd5_a | Q09013 | ENSG00000104936 | DMPK | 98.70 | 3.90E-12 | 4.70E-16 | 132.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | TGRH88_017420 |
TGRH88_017420 |
Toxoplasma gondii | 3dxn_a | Q3HNM6 | 98.60 | 1.00E-11 | 1.20E-15 | 121.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | Camk2d Kiaa4163 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) |
2.7.11.17 | Mus musculus | 6bab_a | Q6PHZ2 | 98.50 | 2.50E-11 | 3.10E-15 | 119.50 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | PASK KIAA0135 |
PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Niemann-Pick Disease, Type C1 |
3dls_a | Q96RG2 | ENSG00000115687 | PASK | 98.60 | 1.10E-11 | 1.30E-15 | 125.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PLK4 SAK STK18 |
Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak) |
2.7.11.21 | Homo sapiens | Congenital Nervous System Abnormality,Autosomal Recessive Chorioretinopathy-Microcephaly Syndrome,Colorectal Cancer,Microcephaly,Seckel Syndrome,Microcephaly And Chorioretinopathy, Autosomal Recessive, 2,Isolated Growth Hormone Deficiency,Primary Autosomal Recessive Microcephaly,Joubert Syndrome 1,Isolated Growth Hormone Deficiency, Type Ia |
3cok_b | O00444 | ENSG00000142731 | PLK4 | 98.80 | 8.30E-13 | 1.00E-16 | 127.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CDKL5 STK9 |
Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9) |
2.7.11.22 | Homo sapiens | Cdkl5 Deficiency Disorder,Ohtahara Syndrome,Seizure Disorder,Childhood Absence Epilepsy,Epilepsy,Gait Apraxia,Gene Duplication Disease,Nicolaides-Baraitser Syndrome,Amyotrophic Lateral Sclerosis 1,Angelman Syndrome,Focal Epilepsy,Developmental And Epileptic Encephalopathy 14,Epilepsy With Generalized Tonic-Clonic Seizures,Congenital Nervous System Abnormality,Developmental And Epileptic Encephalopathy,Fundus Dystrophy,Juvenile Retinoschisis,Bruxism,X-Linked Congenital Retinoschisis,Early Myoclonic Encephalopathy,Stxbp1 Encephalopathy,Microcephaly,Mental Retardation, Autosomal Dominant 20,Encephalopathy,Benign Neonatal Seizures,Alacrima, Achalasia, And Mental Retardation Syndrome,Benign Epilepsy With Centrotemporal Spikes,Developmental And Epileptic Encephalopathy 9,Methylmalonic Acidemia,Benign Familial Neonatal Epilepsy,West Syndrome,Disease Of Mental Health,Lubs X-Linked Mental Retardation Syndrome,Fragile X Syndrome,Pitt-Hopkins Syndrome,Mowat-Wilson Syndrome,Developmental And Epileptic Encephalopathy 2,Lennox-Gastaut Syndrome,Sturge-Weber Syndrome,Neonatal Period Electroclinical Syndrome,Infancy Electroclinical Syndrome,Childhood Electroclinical Syndrome,Early Infantile Epileptic Encephalopathy,Developmental And Epileptic Encephalopathy 4,Myasthenic Syndrome, Congenital, 11, Associated With Acetylcholine Receptor Deficiency,Encephalopathy Due To Defective Mitochondrial And Peroxisomal Fission 1,Aicardi Syndrome,Specific Developmental Disorder,Pervasive Developmental Disorder,Dravet Syndrome,Developmental And Epileptic Encephalopathy 1,Benign Familial Infantile Epilepsy,Generalized Epilepsy With Febrile Seizures Plus,Pyruvate Dehydrogenase E1-Alpha Deficiency,Retinoschisis 1, X-Linked, Juvenile,Rett Syndrome,Epilepsy, Myoclonic Juvenile,Autism,Christianson Syndrome,Epilepsy, Idiopathic Generalized,Peho Syndrome |
4bgq_a | O76039 | ENSG00000008086 | CDKL5 | 98.60 | 6.00E-12 | 7.70E-16 | 121.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | FGFR2 BEK KGFR KSAM |
Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332) |
2.7.10.1 | Homo sapiens | Bone Disease,Acanthosis Nigricans,Bone Development Disease,Achondroplasia,Physical Disorder,Uterine Carcinosarcoma,Endometrial Cancer,Apert Syndrome,Clear Cell Acanthoma,Autosomal Dominant Polycystic Kidney Disease,Saethre-Chotzen Syndrome,Acanthoma,Squamous Cell Carcinoma,Pfeiffer Syndrome,Lung Cancer Susceptibility 3,Calcinosis,Polycystic Kidney Disease,Pleuropulmonary Blastoma,Acne,Dysostosis,Exophthalmos,Familial Scaphocephaly Syndrome,Exposure Keratitis,Synostosis,Dysgerminoma,Skin Tag,Rasopathy,Deafness, Autosomal Recessive 71,Ectodermal Dysplasia,Brachyolmia Type 4 With Mild Epiphyseal And Metaphyseal Changes,Holoprosencephaly,Split Hand-Foot Malformation,Ankylosis,Cervical Keratinizing Squamous Cell Carcinoma,Radioulnar Synostosis,Ankyloblepharon-Ectodermal Defects-Cleft Lip/Palate,Plagiocephaly,Syndromic Craniosynostosis,Craniosynostosis,Chronic Inflammation Of Lacrimal Passage,Dacryocystocele,Bile Duct Adenocarcinoma,Esophagus Adenocarcinoma,Nevus, Epidermal,Luteoma,Testicular Spermatocytic Seminoma,Intrahepatic Cholangiocarcinoma,Glioma,Fibrolamellar Carcinoma,Hepatocellular Clear Cell Carcinoma,Cytochrome P450 Oxidoreductase Deficiency,Fgfr Craniosynostosis Syndromes,Bladder Cancer,Pigmentation Disease,Wolffian Duct Adenocarcinoma,Osteoglophonic Dysplasia,Endometrial Adenocarcinoma,Adult Teratoma,Ovarian Cancer,Adenocarcinoma,Eccrine Papillary Adenocarcinoma,Breast Cancer,Glioblastoma,Wells Syndrome,Colorectal Cancer,Hypospadias,Hydrocephalus,Cholesteatoma Of Middle Ear,Scaphocephaly, Maxillary Retrusion, And Mental Retardation,Muenke Syndrome,Syringomyelia,Myxoid Liposarcoma,Van Der Woude Syndrome 1,Cleft Palate, Isolated,Cleidocranial Dysplasia,Gastric Cancer,Prostate Cancer,Disease Of Mental Health,Cholangiocarcinoma,Craniosynostosis 1,Jackson-Weiss Syndrome,Kallmann Syndrome,Crouzon Syndrome,Beare-Stevenson Cutis Gyrata Syndrome,Skin Disease,Gastric Adenocarcinoma,Porokeratosis,Aplasia Of Lacrimal And Salivary Glands,Lung Squamous Cell Carcinoma,Ectrodactyly, Ectodermal Dysplasia, And Cleft Lip/Palate Syndrome 1,Hydrocephalus, Congenital, 1,Antley-Bixler Syndrome,Split-Hand/Foot Malformation 1,Esophageal Cancer,Hypertelorism, Microtia, Facial Clefting Syndrome,Odontochondrodysplasia,Orofacial Cleft,Strabismus,Hemifacial Hyperplasia,Chromosome 2q35 Duplication Syndrome,Tooth Agenesis,Thanatophoric Dysplasia, Type I,Renal Hypodysplasia/Aplasia 1,Humeroradial Synostosis,Vesicoureteral Reflux 1,Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans,Nasopharyngeal Carcinoma,Bent Bone Dysplasia Syndrome,Hypertelorism,Hypochondroplasia,Estrogen-Receptor Positive Breast Cancer,Carpenter Syndrome 1,Lacrimoauriculodentodigital Syndrome,Scoliosis,Antley-Bixler Syndrome Without Genital Anomalies Or Disordered Steroidogenesis,Chromosomal Duplication Syndrome,Lung Cancer,Pancreatic Cancer,Peters-Plus Syndrome,Multiple Pterygium Syndrome, Escobar Variant |
2psq_a | P21802 | ENSG00000066468 | FGFR2 | 98.50 | 1.20E-11 | 1.50E-15 | 125.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PRKAA2 AMPK AMPK2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) |
2.7.11.27,2.7.11.31, | Homo sapiens | Hyperglycemia,Hypertrophic Cardiomyopathy,Glycogen Storage Disease,Phosphorylase Kinase Deficiency,Tuberous Sclerosis,Breast Cancer,Ischemia,Aromatase Deficiency,Peutz-Jeghers Syndrome,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Wolff-Parkinson-White Syndrome |
2h6d_a | P54646 | ENSG00000162409 | PRKAA2 | 98.70 | 1.80E-12 | 2.30E-16 | 124.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | STK38 NDR1 |
Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1) |
2.7.11.1 | Homo sapiens | Myeloproliferative Syndrome, Transient,Wilson-Turner X-Linked Mental Retardation Syndrome |
6bxi_a | Q15208 | ENSG00000112079 | STK38 | 98.50 | 2.20E-11 | 2.70E-15 | 122.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | P0510F09.27 |
P0510F09.27 |
Oryza sativa | 3sv0_a | Q8LR51 | 98.60 | 1.30E-11 | 1.40E-15 | 134.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | Taok2 Tao2 |
Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) |
2.7.11.1 | Rattus norvegicus | 1u5r_b | Q9JLS3 | 98.50 | 1.40E-11 | 1.70E-15 | 125.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | CPK2 CDPK2 |
Calcium-dependent protein kinase 2 (EC 2.7.11.1) (PfCDPK2) |
2.7.11.1 | Plasmodium falciparum | 4mvf_a | O15865 | 98.60 | 8.00E-12 | 9.70E-16 | 132.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | PHKG1 PHKG |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26) |
2.7.11.1,2.7.11.19,2.7.11.26 | Oryctolagus cuniculus | 2phk_a | P00518 | 98.70 | 2.10E-12 | 2.70E-16 | 122.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | KDR FLK1 VEGFR2 |
Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309) |
2.7.10.1 | Homo sapiens | Psoriasis,Pancreatic Adenocarcinoma,Corneal Neovascularization,Mesothelioma, Malignant,Skin Melanoma,Pneumothorax,Heart Disease,Neovascular Glaucoma,Endocrine Gland Cancer,Retinal Vein Occlusion,Retinal Vascular Occlusion,Vascular Cancer,Retinitis Pigmentosa,Thyroid Gland Cancer,Ovarian Hyperstimulation Syndrome,Lung Cancer Susceptibility 3,Chronic Myelomonocytic Leukemia,Bone Cancer,Microvascular Complications Of Diabetes 5,Mast-Cell Leukemia,Melanoma,Malignant Ciliary Body Melanoma,Lung Non-Squamous Non-Small Cell Carcinoma,Diabetes Mellitus,Degeneration Of Macula And Posterior Pole,Macular Retinal Edema,Clear Cell Renal Cell Carcinoma,Septate Uterus,Primary Cutaneous B-Cell Lymphoma,Myocardial Infarction,Breast Angiosarcoma,Eye Degenerative Disease,Placenta Accreta,Cavernous Hemangioma,Neuroblastoma,Pilocytic Astrocytoma,Epithelioid Hemangioendothelioma,Arteriovenous Malformations Of The Brain,Olecranon Bursitis,Pulmonary Vein Stenosis,Retinal Vascular Disease,Gastroesophageal Junction Adenocarcinoma,Leukemia, Acute Myeloid,Capillary Disease,Hematologic Cancer,Hemangioma,Radiation Proctitis,Kidney Cancer,Leukostasis,Aortic Valve Disease 1,Hemangioblastoma,Bladder Cancer,Capillary Hemangioma,Heritable Pulmonary Arterial Hypertension,Retinal Artery Occlusion,Fundus Dystrophy,Parasitic Protozoa Infectious Disease,Kaposiform Hemangioendothelioma,Nodular Goiter,Background Diabetic Retinopathy,Endometriosis,Pediculus Humanus Capitis Infestation,Vein Disease,Bursitis,Ovarian Cancer,Hemangioma, Capillary Infantile,Adenocarcinoma,Pre-Eclampsia,Eye Disease,Cervical Adenosquamous Carcinoma,Breast Carcinoma In Situ,Breast Cancer,Glioblastoma,Squamous Cell Carcinoma, Head And Neck,Rosacea,High Grade Glioma,Gliosarcoma,Colorectal Cancer,Familial Hypercholesterolemia,Hepatocellular Carcinoma,Proctitis,Premature Menopause,8p11 Myeloproliferative Syndrome,Clopidogrel Resistance,Kuhnt-Junius Degeneration,Angiokeratoma Of Mibelli,Angiokeratoma Circumscriptum,Pheochromocytoma,Rhabdomyosarcoma,Ischemia,Cerebral Cavernous Malformations,Conjunctival Vascular Disease,Macular Degeneration, Age-Related, 1,Sarcoma,Hantavirus Pulmonary Syndrome,Fibrosarcoma Of Bone,Skin Carcinoma,Gastric Cancer,Lymphangioma,Mobitz Type Ii Atrioventricular Block,Prostate Cancer,Disease Of Mental Health,Coats Disease,Microvascular Complications Of Diabetes 1,Pulmonary Hypertension,Type 2 Diabetes Mellitus,Angiosarcoma,Drug-Induced Lupus Erythematosus,Placental Insufficiency,Thyroid Gland Follicular Carcinoma,Merkel Cell Carcinoma,Thyroid Gland Medullary Carcinoma,Renal Cell Carcinoma, Papillary, 1,Esophageal Cancer,Exudative Vitreoretinopathy 1,Tetralogy Of Fallot,Myelodysplastic Syndrome,Sorsby Fundus Dystrophy,Ewing Sarcoma,Gastrointestinal Stromal Tumor,Varicose Veins,Hirschsprung Disease 1,Limb Ischemia,Bone Squamous Cell Carcinoma,Renal Cell Carcinoma, Nonpapillary,Mucosal Melanoma,Hypertension, Essential,Lipoprotein Quantitative Trait Locus,Cardiovascular Organ Benign Neoplasm,Intussusception,Moyamoya Disease 1,Premature Ovarian Failure 1,Medulloblastoma,Lung Cancer,Pancreatic Cancer |
4ase_a | P35968 | ENSG00000128052 | KDR | 98.50 | 2.30E-11 | 2.80E-15 | 122.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | Rop2 |
Rop2 |
Toxoplasma gondii | 3dzo_a | Q06AK3 | 98.60 | 8.50E-12 | 9.80E-16 | 131.00 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | AAK1 KIAA1048 |
AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1) |
2.7.11.1 | Homo sapiens | Parkinson Disease, Late-Onset,Cataract 8, Multiple Types,Hepatitis C Virus,Rabies |
5te0_a | Q2M2I8 | ENSG00000115977 | AAK1 | 98.60 | 4.20E-12 | 5.10E-16 | 128.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | aurkb-a airk2-a |
Aurora kinase B-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 2-A) (AIRK2-A) (XAIRK2-A) (Serine/threonine-protein kinase 12-A) (Serine/threonine-protein kinase aurora-B-A) (xAurora-B) |
2.7.11.1 | Xenopus laevis | 4c2v_b | Q6DE08 | 98.70 | 1.50E-12 | 1.80E-16 | 126.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | CAMK1G CLICK3 VWS1 |
Calcium/calmodulin-dependent protein kinase type 1G (EC 2.7.11.17) (CaM kinase I gamma) (CaM kinase IG) (CaM-KI gamma) (CaMKI gamma) (CaMKIG) (CaMK-like CREB kinase III) (CLICK III) |
2.7.11.17 | Homo sapiens | 2jam_a | Q96NX5 | ENSG00000008118 | CAMK1G | 98.50 | 2.00E-11 | 2.50E-15 | 121.30 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YOL100W | PKH2 | SGDID:S000005460 | PTSG_10090 |
PTSG_10090 |
2.7.11.17 | Salpingoeca rosetta | 5ig1_b | F2UPG5 | 98.70 | 3.80E-12 | 4.50E-16 | 129.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | ROCK2 KIAA0619 |
Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2) |
2.7.11.1 | Homo sapiens | Coronary Artery Vasospasm,Dextrocardia,Ureteral Obstruction,Breast Cancer,Tongue Squamous Cell Carcinoma,Hypertension, Essential |
4wot_b | O75116 | ENSG00000134318 | ROCK2 | 98.70 | 2.00E-12 | 2.40E-16 | 134.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | Rps6ka3 Mapkapk1b Rps6ka-rs1 Rsk2 |
Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) |
2.7.11.1 | Mus musculus | 4el9_a | P18654 | 98.50 | 1.50E-11 | 1.80E-15 | 121.30 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | PLK1 PLK |
Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) |
2.7.11.21 | Homo sapiens | Breast Papillomatosis,Squamous Cell Carcinoma,Cornelia De Lange Syndrome,Leukemia, Chronic Myeloid,Gonococcal Keratitis,Leukemia, Acute Myeloid,Trichothiodystrophy 1, Photosensitive,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Microcephaly,Rhabdomyosarcoma,Gastric Cancer,Prostate Cancer,Lung Squamous Cell Carcinoma,Lymphoma, Non-Hodgkin, Familial,Dyskeratosis Congenita, Autosomal Dominant 3,Esophageal Cancer,Brain Glioma,Ataxia-Telangiectasia,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer,Pancreatic Cancer |
2owb_a | P53350 | ENSG00000166851 | PLK1 | 98.60 | 6.30E-12 | 7.40E-16 | 127.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CAMK1 |
Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) |
2.7.11.17 | Homo sapiens | Acrofacial Dysostosis 1, Nager Type |
4fg7_a | Q14012 | ENSG00000134072 | CAMK1 | 98.70 | 1.70E-12 | 2.10E-16 | 127.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CDKL3 NKIAMRE |
Cyclin-dependent kinase-like 3 (EC 2.7.11.22) (Serine/threonine-protein kinase NKIAMRE) |
2.7.11.22 | Homo sapiens | Orofaciodigital Syndrome Vi |
3zdu_a | Q8IVW4 | ENSG00000006837 | CDKL3 | 98.50 | 1.20E-11 | 1.40E-15 | 123.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PLK3 CNK FNK PRK |
Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) |
2.7.11.21 | Homo sapiens | Breast Cancer |
4b6l_a | Q9H4B4 | ENSG00000173846 | PLK3 | 98.70 | 1.30E-12 | 1.70E-16 | 126.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PDPK1 PDK1 |
3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) |
2.7.11.1 | Homo sapiens | Endometrial Cancer,Noonan Syndrome 1,Esophageal Adenosquamous Carcinoma,Prostate Cancer,Tuberous Sclerosis 1,Lung Cancer |
1h1w_a | O15530 | ENSG00000140992 | PDPK1 | 98.80 | 4.60E-13 | 5.70E-17 | 130.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PAK4 KIAA1142 |
Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) |
2.7.11.1 | Homo sapiens | Polycystic Kidney Disease 3 With Or Without Polycystic Liver Disease |
2j0i_a | O96013 | ENSG00000130669 | PAK4 | 98.50 | 1.80E-11 | 2.20E-15 | 121.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | MARK3 CTAK1 EMK2 |
MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) |
2.7.11.1 | Homo sapiens | Focal Epithelial Hyperplasia,Osteoporosis,Peutz-Jeghers Syndrome,Gaucher Disease, Type Iii,Visual Impairment And Progressive Phthisis Bulbi |
2qnj_b | P27448 | ENSG00000075413 | MARK3 | 98.60 | 4.30E-12 | 5.30E-16 | 126.60 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PRKCQ PRKCT |
Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) |
2.7.11.13 | Homo sapiens | Inflammatory Bowel Disease 1,T-Cell Lymphoblastic Leukemia/Lymphoma,Crohn'S Disease,Breast Cancer,Gastrointestinal Stromal Tumor |
4ra5_a | Q04759 | ENSG00000065675 | PRKCQ | 98.80 | 8.30E-13 | 1.00E-16 | 133.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | ROP 2 |
ROP 2 |
Toxoplasma gondii | 2w1z_b | Q27007 | 98.70 | 2.20E-12 | 2.70E-16 | 130.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | cgd7_1840 |
cgd7_1840 |
Cryptosporidium parvum | 3f3z_a | Q5CYL9 | 98.50 | 2.20E-11 | 2.80E-15 | 116.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | CIPK23 LKS1 PKS17 SnRK3.23 At1g30270 F12P21.6 |
CBL-interacting serine/threonine-protein kinase 23 (EC 2.7.11.1) (Protein LOW-K(+)-SENSITIVE 1) (SNF1-related kinase 3.23) (SOS2-like protein kinase PKS17) |
2.7.11.1 | Arabidopsis thaliana | 4czt_d | Q93VD3 | 98.50 | 2.60E-11 | 2.90E-15 | 131.80 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | Blon_2173 |
Blon_2173 |
Bifidobacterium longum | 4ocv_a | B7GN78 | 99.50 | 2.30E-18 | 2.90E-22 | 174.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | Map3k14 Nik |
Mitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25) (NF-kappa-beta-inducing kinase) (Serine/threonine-protein kinase NIK) |
2.7.11.25 | Mus musculus | 4g3f_a | Q9WUL6 | 98.60 | 7.80E-12 | 9.60E-16 | 125.10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | unc-43 K11E8.1 |
Calcium/calmodulin-dependent protein kinase type II (CaM kinase II) (EC 2.7.11.17) (Uncoordinated protein 43) |
2.7.11.17 | Caenorhabditis elegans | 2bdw_b | O62305 | 98.70 | 3.80E-12 | 4.50E-16 | 130.50 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | PHKG2 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) |
2.7.11.19 | Homo sapiens | Glycogen Storage Disease Ixa,Glycogen Storage Disease Ixc,Glycogen Storage Disease,Phosphorylase Kinase Deficiency,Glycogen Storage Disease Due To Liver Phosphorylase Kinase Deficiency,Glycogen Storage Disease Ia,Glycogen Storage Disease, Type Ixd,Glycogen Storage Disease Ix,Glycogen Storage Disease Ixb |
2y7j_c | P15735 | ENSG00000156873 | PHKG2 | 98.80 | 4.40E-13 | 5.30E-17 | 136.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CDK7 CAK CAK1 CDKN7 MO15 STK1 |
Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) |
2.7.11.22,2.7.11.23, | Homo sapiens | Myofibrillar Myopathy,Cockayne Syndrome,Breast Cancer,Xeroderma Pigmentosum, Complementation Group D,Xeroderma Pigmentosum, Variant Type,Xeroderma Pigmentosum, Complementation Group B |
1ua2_b | P50613 | ENSG00000134058 | CDK7 | 98.50 | 1.40E-11 | 1.70E-15 | 123.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CAMK2D CAMKD |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) |
2.7.11.17 | Homo sapiens | Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1dd |
2vn9_a | Q13557 | ENSG00000145349 | CAMK2D | 98.50 | 2.30E-11 | 2.80E-15 | 119.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CPK4 CDPK4 PF07_0072 |
Calcium-dependent protein kinase 4 (EC 2.7.11.1) |
2.7.11.1 | Plasmodium falciparum | 4rgj_a | Q8IBS5 | 98.70 | 2.60E-12 | 3.30E-16 | 135.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | CDPK1 |
CDPK1 |
Toxoplasma gondii | 3nyv_a | Q9BJF5 | 98.50 | 3.00E-11 | 3.80E-15 | 126.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YOL100W | PKH2 | SGDID:S000005460 | AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 |
Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) |
2.7.11.1 | Homo sapiens | Endometrial Cancer,Melanoma,Plasma Cell Neoplasm,Uterine Corpus Cancer,Atypical Teratoid Rhabdoid Tumor,Neuroblastoma,Childhood Malignant Schwannoma,Adult Malignant Schwannoma,Bladder Cancer,Laryngeal Squamous Cell Carcinoma,Tetraploidy,Ovarian Cancer,Prostate Neuroendocrine Neoplasm,Breast Cancer,Colorectal Cancer,Endometrial Serous Adenocarcinoma,Hepatocellular Carcinoma,Rhabdomyosarcoma,Gastric Cancer,Prostate Cancer,Cervical Cancer,Lynch Syndrome,Esophageal Cancer,Donohue Syndrome,Colorectal Adenocarcinoma,Myeloma, Multiple,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer,Pancreatic Cancer |
3h10_a | O14965 | ENSG00000087586 | AURKA | 98.80 | 5.90E-13 | 7.50E-17 | 127.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | OXSR1 KIAA1101 OSR1 |
Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) |
2.7.11.1 | Homo sapiens | Bartter Disease,Arthrogryposis, Distal, Type 3,Hypomagnesemia 4, Renal,Distal Arthrogryposis,Hypomagnesemia 3, Renal |
2vwi_c | O95747 | ENSG00000172939 | OXSR1 | 98.50 | 2.40E-11 | 3.10E-15 | 117.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PRKCH PKCL PRKCL |
Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) |
2.7.11.13 | Homo sapiens | Myofibrillar Myopathy,Amphetamine Abuse,Stroke, Ischemic,Glioblastoma |
3txo_a | P24723 | ENSG00000027075 | PRKCH | 98.80 | 4.10E-13 | 5.00E-17 | 136.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | pknA Rv0015c MTCY10H4.15c |
Serine/threonine-protein kinase PknA (EC 2.7.11.1) |
2.7.11.1 | Mycobacterium tuberculosis | 6b2q_b | P9WI83 | 98.60 | 8.20E-12 | 9.90E-16 | 124.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | CAMK4 CAMK CAMK-GR CAMKIV |
Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) |
2.7.11.17 | Homo sapiens | Lung Large Cell Carcinoma,Alacrima, Achalasia, And Mental Retardation Syndrome,Disease Of Mental Health,Crouzon Syndrome With Acanthosis Nigricans,Systemic Lupus Erythematosus,Gingival Fibromatosis |
2w4o_a | Q16566 | ENSG00000152495 | CAMK4 | 98.60 | 7.90E-12 | 9.20E-16 | 128.00 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CDKL2 |
Cyclin-dependent kinase-like 2 (EC 2.7.11.22) (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE) |
2.7.11.22 | Homo sapiens | Papillary Serous Adenocarcinoma,Orofaciodigital Syndrome Vi |
4aaa_a | Q92772 | ENSG00000138769 | CDKL2 | 98.50 | 1.90E-11 | 2.30E-15 | 123.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | pknB MRA_0016 |
pknB MRA_0016 |
2.7.11.1 | Mycobacterium tuberculosis | 3ork_a | A5TY84 | 98.50 | 2.20E-11 | 2.80E-15 | 119.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | EIF2AK3 PEK PERK |
Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK) |
2.7.11.1 | Homo sapiens | Skin Melanoma,Retinitis Pigmentosa,Neonatal Diabetes,Prion Disease,Diabetes Mellitus,Alzheimer Disease,Rasopathy,Retinal Degeneration,Subungual Glomus Tumor,Crisponi/Cold-Induced Sweating Syndrome 1,Osteoporosis,Wolfram Syndrome,Epiphyseal Dysplasia, Multiple, With Early-Onset Diabetes Mellitus,Disease Of Mental Health,Leukoencephalopathy With Vanishing White Matter,Odontochondrodysplasia,Trichothiodystrophy 5, Nonphotosensitive,Cardiomyopathy, Familial Hypertrophic, 25,Permanent Neonatal Diabetes Mellitus,Palmoplantar Keratoderma, Bothnian Type |
4g31_a | Q9NZJ5 | ENSG00000172071 | EIF2AK3 | 98.70 | 3.40E-12 | 4.40E-16 | 123.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | BIK1 At2g39660 F12L6.32 F17A14.3 |
Serine/threonine-protein kinase BIK1 (EC 2.7.11.1) (Protein BOTRYTIS-INDUCED KINASE 1) |
2.7.11.1 | Arabidopsis thaliana | 5tos_a | O48814 | 98.50 | 2.00E-11 | 2.40E-15 | 126.00 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | FES FPS |
Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) |
2.7.10.2 | Homo sapiens | Melanoma,Leukemia, Chronic Myeloid,Latent Syphilis,Sjogren-Larsson Syndrome,Leukemia,Myeloid Leukemia,Sarcoma,Ewing Sarcoma Of Bone,Neurofibrosarcoma,Acute Promyelocytic Leukemia,Miller-Dieker Lissencephaly Syndrome,Myopathy, Centronuclear, 2 |
3cbl_a | P07332 | ENSG00000182511 | FES | 98.50 | 2.30E-11 | 2.80E-15 | 122.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PRKCI DXS1179E |
Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) |
2.7.11.13 | Homo sapiens | Glioblastoma,Lung Squamous Cell Carcinoma,Lung Cancer |
3a8x_a | P41743 | ENSG00000163558 | PRKCI | 98.60 | 8.70E-12 | 1.10E-15 | 125.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | PRKAA1 AMPK1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) |
2.7.11.26,2.7.11.27,2.7.11.31 | Homo sapiens | Mixed Fibrolamellar Hepatocellular Carcinoma,Fatty Liver Disease,Breast Cancer,Body Mass Index Quantitative Trait Locus 11,Type 2 Diabetes Mellitus,Wolff-Parkinson-White Syndrome,Lung Cancer |
4red_a | Q13131 | ENSG00000132356 | PRKAA1 | 98.60 | 9.80E-12 | 1.20E-15 | 127.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | TNNI3K CARK |
Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase) |
2.7.11.1 | Homo sapiens | Dilated Cardiomyopathy,Restrictive Cardiomyopathy,Cardiac Conduction Disease With Or Without Dilated Cardiomyopathy,Familial Atrial Fibrillation |
4yfi_a | Q59H18 | ENSG00000259030 | FPGT-TNNI3K | 98.50 | 1.70E-11 | 2.20E-15 | 120.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | MYLK4 SGK085 |
Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085) |
2.7.11.1 | Homo sapiens | Cardiomyopathy, Familial Restrictive, 2,Deafness, Autosomal Recessive 17,Deafness, Autosomal Recessive 14,Cardiomyopathy, Familial Restrictive, 3 |
2x4f_a | Q86YV6 | ENSG00000145949 | MYLK4 | 98.70 | 1.90E-12 | 2.30E-16 | 133.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | MAP3K14 NIK |
Mitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25) (NF-kappa-beta-inducing kinase) (HsNIK) (Serine/threonine-protein kinase NIK) |
2.7.11.25 | Homo sapiens | T-Cell Lymphoblastic Leukemia/Lymphoma,Nik Deficiency,Trichohepatoenteric Syndrome 1,Pancreatic Adenosquamous Carcinoma,Pancreatic Ductal Adenocarcinoma,Immunodeficiency 50 |
4idv_c | Q99558 | ENSG00000006062 | MAP3K14 | 98.50 | 1.60E-11 | 1.90E-15 | 124.10 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | CHEK1 CHK1 |
Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) |
2.7.11.1 | Homo sapiens | Tongue Carcinoma,Neuroblastoma,Leukemia, Acute Myeloid,Sporadic Breast Cancer,Cerebellar Disease,Ovarian Cancer,Breast Cancer,Colorectal Cancer,Microcephaly,Xeroderma Pigmentosum, Variant Type,Fanconi Anemia, Complementation Group A,Retinoblastoma,Esophageal Cancer,Seckel Syndrome,Mantle Cell Lymphoma,Pigmentary Disorder, Reticulate, With Systemic Manifestations, X-Linked,Ovarian Clear Cell Carcinoma,Autosomal Recessive Cerebellar Ataxia,Li-Fraumeni Syndrome,Ataxia-Telangiectasia,Medulloblastoma,Primary Autosomal Recessive Microcephaly,Lung Cancer |
2e9v_b | O14757 | ENSG00000149554 | CHEK1 | 98.70 | 3.60E-12 | 4.60E-16 | 120.70 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | STK17B DRAK2 |
Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2) |
2.7.11.1 | Homo sapiens | Colon Squamous Cell Carcinoma |
3lm5_a | O94768 | ENSG00000081320 | STK17B | 98.60 | 4.50E-12 | 5.40E-16 | 127.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YOL100W | PKH2 | SGDID:S000005460 | RAD53 MEC2 SAD1 SPK1 YPL153C P2588 |
Serine/threonine-protein kinase RAD53 (EC 2.7.12.1) (CHEK2 homolog) (Serine-protein kinase 1) |
2.7.12.1 | Saccharomyces cerevisiae | 4pdp_a | P22216 | 98.70 | 3.70E-12 | 4.50E-16 | 128.80 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | Prkcb Pkcb Prkcb1 |
Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) |
2.7.11.13 | Rattus norvegicus | 3pfq_a | P68403 | 98.50 | 1.30E-11 | 1.50E-15 | 137.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YOL100W | PKH2 | SGDID:S000005460 | RPS6KA1 MAPKAPK1A RSK1 |
Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) |
2.7.11.1 | Homo sapiens | Tuberous Sclerosis 2,Tuberous Sclerosis,Cardiomyopathy, Familial Hypertrophic, 4,Disease Of Mental Health,Adrenal Cortical Adenocarcinoma,Dyskeratosis Congenita, Autosomal Dominant 3,Tuberous Sclerosis 1,Coffin-Lowry Syndrome,Polycystic Kidney Disease 3 With Or Without Polycystic Liver Disease |
4nif_d | Q15418 | ENSG00000117676 | RPS6KA1 | 98.60 | 6.70E-12 | 8.00E-16 | 126.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |